Case Management of Chemotherapy Induced Anemia (CIA) with Darbepoetin Alfa in a Patient with Metastatic Breast Carcinoma - Dr Adwaita Gore
Written By : Dr Adwaita Gore
Published On 2026-02-09 05:15 GMT | Update On 2026-02-09 06:04 GMT
Advertisement
In this video, Dr. Adwaita A. Gore, Medical Oncologist at S L Raheja Hospital, Mumbai, presents a real-world case highlighting the management of chemotherapy-induced anemia (CIA) in a patient with metastatic breast cancer receiving CDK 4/6 inhibitor–based therapy.
The case features a 65-year-old post-menopausal woman with ER-positive, HER2-negative metastatic breast cancer, who achieved good disease control on letrozole and palbociclib but developed severe, symptomatic anemia during prolonged treatment. Chemotherapy-induced anemia is a common yet often under-recognized complication that can significantly impact quality of life and treatment continuity.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.